Sintilimab for Patients with Pretreated EGFR-Mutated Non Small Cell Lung Cancer
Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma
Non Hodgkin Lymphoma Treated with B-Cell Depleting Immunotherapy May Result in Prolonged Hospital Stay and Higher Morbidity after Covid-19 Infection
Artificial Intelligence Can Determine Appropriate Chemotherapy Regimen in Advanced Colorectal Cancer
Genetic Testing in Older Women with Breast Cancer
Initial Management of Noncastrate Prostate Cancer: ASCO Guideline Update
Association of Age at Smoking Initiation and Cessation with Risk of Cancer Mortality
KEYTRUDA® for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
FDA Approves SCEMBLIX® for Chronic Myeloid Leukemia
Randomized Controlled Trial of Central Venous Access Devices for the Delivery of Systemic Anticancer Therapy
Duration of Extended Adjuvant Letrozole after Tamoxifen in Postmenopausal Women with Early Stage Breast Cancer
ASH 2021 Guidelines for Management of VTE in Patients with Cancer
Omitting Axillary Lymph Node Dissection in Patients with Clinically Positive Axillary Lymph Nodes Treated with Neoadjuvant Chemotherapy
FDA Approves TECENTRIQ® as Adjuvant Treatment for Non Small Cell Lung Cancer
Association between Antibiotic Use and Colorectal Cancer
Durable Survival Benefit with First Line OPDIVO® plus YERVOY® and a Limited Course of Chemotherapy
Late Breaking Abstract – ESMO 2021: Adjuvant KEYTRUDA® for High Risk Stage II Melanoma
Late Breaking Abstract – ESMO 2021: Keytruda® Plus Chemotherapy in Advanced Cervical Cancer
Late Breaking Abstract – ESMO 2021: ENHERTU® Superior to KADCYLA® in Patients with HER2 Positive Metastatic Breast Cancer
PSMA Targeted Therapy Improves Overall Survival in Metastatic Prostate Cancer
Bottom Ad
Advertisement
Subscribe
